Daily filing brief

8 Important BSE and NSE Announcements for 8 September 2026

By Daily BrieferPublished Updated

Tata Capital allotted Rs 3,000 crore of secured NCDs, while Raymond approved the issue of convertible warrants for up to ₹214.71 crore. We also cover capital restructuring, delayed results, credit ratings and corporate insolvency updates in our 8 September 2026 edition.

  1. Tata Capital Limited Allots Secured NCDs via Private Placement

    Allotment of Securities

    NCD Private Placement Details

    • 3,00,000 secured redeemable NCDs allotted on a private placement.
    • Issue size Rs 3000 crore; coupon 8.05% p.a.; maturity 07 Sep 2029.
    • Security: pari-passu charge on moveable receivables and book debts.
    View source
  2. Raymond Ltd

    Raymond approves issue of 33,28,686 convertible warrants to Minerva Ventures Fund for ₹214.71 crore

    Preferential Issue

    Issue overview

    • Fundraise through 33,28,686 convertible warrants for cash at ₹645 each.
    • Aggregate consideration up to ₹214.71 crore.

    Warrant terms

    • Each warrant allows one equity share; conversion within 18 months.
    • Unexercised warrants lapse after 18 months with upfront amount forfeited.

    Allottee and shareholding

    • Proposed allottee: Minerva Ventures Fund; one investor.
    • Post-issue fully diluted holding: 4.35% for Minerva.

    Approvals

    • Subject to shareholders’ approval and other regulatory clearances.

    Other notes

    • Issue is a private placement via preferential issue; cash consideration.
    View source
  3. Shree Securities approves capital reduction and consolidation to extinguish losses; governance changes underway; AGM Sept 29, 2026

    Reg. 34 (1) Annual Report

    Financial performance

    • Revenue from operations: ₹74.70 Lakhs in FY2025-26, up from ₹68.35 Lakhs.
    • Total income: ₹74.70 Lakhs for FY2025-26.
    • Expenses: ₹68.53 Lakhs; finance cost ₹14.38 Lakhs; other expenses ₹54.15 Lakhs.
    • Profit before tax: ₹6.17 Lakhs in FY2025-26.
    • Profit after tax: ₹6.17 Lakhs; prior year ₹65.72 Lakhs.
    • Basic EPS: ₹0.001; prior year ₹0.008.
    • Dividend declared: none in FY2025-26.
    • Net cash from operating activities: positive; approx ₹11.9 Lakhs.

    Capital restructuring

    • 33rd AGM scheduled for 29 September 2026 (VC/OAVM).
    • Capital reduction and consolidation approved to extinguish ₹78.20 Crore losses.
    • Pre-reduction capital ₹79.80 Crore; post-reduction ₹1.596 Crore; consolidation to 15,96,000 shares of ₹10.
    • Effective date after NCLT order; Record Date within 90 days.
    • Scheme preserves creditor rights; no cash payout; listing continues.

    Governance & board changes

    • Udayan S. Kachchhy appointed Non-Executive Independent Director for five years.
    • Priyanka Singh resigned as Independent Director on 16 Sep 2025.
    • CFO Shubham Gupta and Company Secretary Varsha Maniar resigned in 2025.
    • Gurdeep Singh appointed CS & Compliance Officer on 22 Jun 2026.
    • Auditors: Sunit M. Chhatbar appointed; RK Kankaria resigned 10 Aug 2026.
    • Secretarial Auditor: Kirti Sharma & Associates.
    • Audit Committee comprises three Independent Directors.

    Audits & compliance

    • Audit emphasis: unsecured loans ₹3.15 Crore at concessional 4% interest.
    • Multiple SEBI LO DR fines for late filings; company to comply going forward.
    • Secretarial MR-3 issued; governance observations to be addressed.
    • Governance disclosures and certifications published on company website.

    Operations & risk

    • Company is an NBFC; focus on loans and investments; prudent lending.
    • Capital reduction central to restoring financial position; no new business expansion disclosed.
    • No public deposits accepted; going concern maintained after restructuring.

    Shareholding & listing

    • Post-scheme equity capital reduces to ₹1.596 Crore; 15.96 lakh shares of ₹10.
    • Shareholding pattern remains pro rata; no change in control.
    • Promoters hold 0.44%; Public holds 99.56% as of 31.03.2026.
    • Dematerialization: 70.83% with CDSL; 29.12% with NSDL; 0.05% physical.

    AGM & notices

    • 33rd AGM notice available on company website and stock exchanges.
    • E-voting facility via CDSL/NSDL; voting window 26-28 Sep 2026.
    • Record date to be fixed after approval; attendance via VC/OAVM.

    Other disclosures

    • Related party transactions disclosed per IND AS 24; no material deals this year.
    • Whistle blower policy and code of conduct published on website.
    • Company complies with mandatory SEBI LO DR requirements; compliance certificates issued.
    View source
  4. Futura Polyesters to disclose backlogged results from Sep-2020 to Mar-2025; trading suspension to be lifted

    Financial Results

    Filing status

    • Plans to disclose pending results for quarters from Sep 30, 2020 to Mar 31, 2025.
    • Board approved several past quarterly results in June 2026; backlogs due to staff shortages.
    • Trading suspension to be lifted after disclosures; results to be uploaded on the company website.

    Auditor remarks

    • Auditor cites potential understatement of finance costs due to non-recognition; going concern uncertainty.
    • Qualified conclusion reflecting these concerns and possible misstatements.

    Debt settlement & regulatory status

    • Paid Rs 243.45 crore OTS to consortium lenders on June 23, 2025; No Dues certificates obtained.
    • Non-compliance with Regulation 33; pending past results to be disclosed with timely filings.

    Business profile

    • Single reportable segment: manufacturing of polyester products; discontinued since 2012.
    View source
  5. CRISIL Upgrades Tatva Chintan Pharma Chem Ltd Long-Term to A-/Stable, Short-Term to A2+

    Credit Rating

    Rating action

    • Long-term rating upgraded to CRISIL A-/Stable, from CRISIL BBB+/Stable.
    • Short-term rating upgraded to CRISIL A2+, from CRISIL A2; Outlook Stable.
    • Total bank loan facilities rated: Rs 245 crore.
    • CRISIL maintains ratings under continuous surveillance; can be revised or withdrawn.
    • Rating letter valid till March 31, 2027.
    View source
  6. NCLT dismisses CIRP against EKI Energy Services; pre-existing contract dispute blocks insolvency process

    Updates - Corporate Insolvency Resolution Process (CIRP)

    CIRP status and NCLT outcome

    • NCLT Indore Bench dismissed the Section 9 application CP(IB)/56(MP)2025 against EKI Energy Services Ltd.
    • Order pronounced 3 Sep 2026; petition stands dismissed and disposed.
    • Tribunal found a real, plausible pre-existing dispute before the demand notice, blocking admission under Section 9.
    • Court clarified it is not adjudicating merits and left remedies to contract mechanisms; no conclusion on price/quantum.
    • Principal claim amount was INR 1,28,74,296 with interest claimed; order did not rule on enforceability of interest.
    • No CoC/SCC/Monitoring Committee formed since CIRP not initiated.
    View source
  7. XL Energy Ltd

    XL Energy Limited: Post-CIRP resolution in progress; FY2025-26 loss; relisting pending

    Reg. 34 (1) Annual Report

    Financial performance

    • Revenue from operations: NIL for FY2025-26.
    • Other Income: Rs 30.70 Lakhs in FY2025-26.
    • Profit before tax: Rs (308.11) Lakhs in FY2025-26.
    • Profit after tax: Rs (308.11) Lakhs in FY2025-26.
    • Basic and Diluted EPS: (19.24) Rs.

    Capital restructuring

    • Authorized share capital reclassified to 15,00,00,000 equity shares.
    • Equity share capital after restructuring: 16,01,100 shares.
    • Entire promoter/promoter group shares extinguished without consideration.
    • SRAs allotted 15,21,000 equity shares; 80,100 issued to public.
    • Existing public shareholders reconstituted; SRAs hold 95%, public 5%.
    • Balance sheet reflects post-restructuring capital; depository actions pending.

    Listing status and relisting

    • Trading status changed from Delisted to Suspended on 28 May 2025.
    • NSE appeal; NCLAT directions pending; Supreme Court stay on relisting pending final outcome.
    • Relisting and depository actions pending as of 31 March 2026.
    • ROC filings completed; regulatory actions for relisting pending.

    Governance and board transition

    • Board not fully operational; Monitoring Committee oversees governance and plan implementation.
    • As at 31 March 2026, six directors; three Independent Directors; no regular chair.
    • Karishma Jain designated as Executive Director and CFO from 9 December 2025.
    • Suryakant Kadakane Maruti appointed Independent Director from 9 December 2025.
    • Harsh Jain appointed Manager (KMP) from 4 August 2026; subject to AGM.

    Post-year-end changes

    • Post-year-end: Kathuria and Mittal resigned as Independent Directors.
    • Sandeep Hisaria resigned as Whole-Time Director; Pankaj Jain appointed as Independent Director.

    Audits and controls

    • Statutory auditors Pavuluri & Co; Secretarial Suprabhat & Co; Internal Bhavani & Co.
    • Auditors issue a qualified opinion; unresolved resolution plan and relisting delays cited.
    • Material uncertainty about going concern; not modified in opinion.
    • Internal controls adequate but not fully operational during transition.

    Dividends and reserves

    • Dividend for FY2025-26: Nil.
    • No transfers to reserves during the year.

    Related party transactions

    • RPT disclosures in Note 14; SRAs became related parties post-resolution.
    • Equity infusion to SRAs occurred in 2024-25; none in 2025-26.
    • Outstanding balance with Jupiter City Developers: Rs 33.69 Lakhs.

    Outlook and risks

    • Outlook tied to completion of Resolution Plan actions and relisting.
    • Risks include NSE/NCLAT appeals and regulatory clearance delays.
    • Liquidity and legacy liabilities management remain key.
    View source
  8. Aerpace Industries Limited FY2025-26: standalone revenue up, large net loss;subsidiary expansion and governance updates

    Reg. 34 (1) Annual Report

    Financial performance

    • Standalone revenue from operations: 213.60 lakh for FY2025-26, up from 161.86.
    • Standalone total income: 403.96 lakh; prior year 302.06.
    • Standalone loss before tax: 1222.55 lakh; prior year 495.69.
    • Standalone net loss: 1200.29 lakh.
    • Consolidated total income: 22.13 lakh; consolidated loss before tax: 1674.97.
    • Consolidated net loss: 1650.30 lakh.
    • Standalone EPS: (0.78) Rs.
    • PPE net carrying amount: 190.44 lakh; CWIP 2,612.99 lakh; intangible assets under development 587.95 lakh.
    • Right-of-use asset: 1,126.49 lakh.
    • Standalone cash flow from operations: (871.32) lakh.
    • Standalone financing cash flow: 2,196.81 lakh.

    Subsidiaries & investments

    • Acquired 75% stake in Aerpace General Trading LLC on 19-Jan-2026.
    • Two subsidiaries as of 31 Mar 2026: Aerpace General Trading LLC and Aerpace Supercars Private Limited.
    • Investment in Aerpace Supercars Private Limited carried at cost: 800.01 lakh.
    • Investment in Aerpace General Trading LLC: 28.58 lakh.

    Governance & board

    • Appointed Prakash Gaur as Additional Non-Executive Director; Darshana Avadhoot Sawant as Independent Director in 2025.
    • Darshana Sawant resigned on 14-Apr-2026; Virendra Verma resigned on 9-Jun-2026.
    • Milan Shah Bhupendra redesignated as Non-Executive Director from 12-May-2026.
    • Anand Manoj Shah redesignated as Managing Director & CFO from 12-May-2026.
    • Anshu Shukla Pandey appointed Independent Director from 10-Jul-2026.
    • RSU 2024 pool increased to 1.45 crore options.

    Capital structure & liquidity

    • Authorized share capital: Rs 40 crore; issued: 15.3857 crore shares (face value Rs 1).
    • Promoters Kaushal Shah and Anand Shah hold about 44.84% and 18.89% respectively.
    • Gearing ratio: 0.60x; Standalone borrowings: 2,568.92 lakh; Consolidated borrowings: 2,710.92 lakh.
    • 96% of shares are in dematerialised form.
    • Cash and cash equivalents: Standalone 2.23 lakh; Consolidated 39.71 lakh.

    Audits & risk

    • Statutory auditors: Ramanand & Associates; Secretarial auditors: Pravesh Palod & Associates.
    • Secretarial audit notes delays in trading window and ESOP disclosures; no material adverse qualifications.
    • Key audit matters include intangible assets under development and impairment in foreign subsidiary.
    • Internal financial controls are adequate; no material weaknesses reported.

    Related party disclosures

    • Material related party transactions include sale of goods/services to Aerpace Supercars: 213.60 lakh.
    • Loans to Aerpace Supercars Private Limited; interest income recorded.
    • Loans to Aerpace Robotics Private Limited; terms and balances disclosed; related party approvals obtained.

    Strategic outlook

    • Execution focus on aerVerse: aerWing, aerDock, aerVolt, and aerOS; manufacturing readiness emphasized.
    • International expansion via UAE subsidiary; opportunities evaluated as verticals mature.
    • Continued technology collaborations to build domestic capabilities and ensure localisation.
    View source